LIVN News and Press, LivaNova PLC From 03/20/24

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its OSPREY clinical study, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation , has achieved a positive predictive outcome and will conclude enrollment earlier than anticipated...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the pricing of $300 million aggregate principal amount of 2.50% convertible senior notes due 2029 (the “notes”) to be issued in a private offering only to persons reasonably believed to be qual...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its intention to offer $300 million aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private offering only to persons reasonably believed to be qualified insti...

2024-02-21 10:36:02 ET LivaNova PLC (LIVN) Q4 2023 Earnings Conference Call February 21, 2024 08:00 A.M. ET Company Participants Matthew Dodds - SVP, Corporate Development & IT William Cozy - Chairman and Interim CEO Alex Shvartsburg - CFO Stephanie Bolto...

2024-02-21 06:01:43 ET More on LivaNova PLC LivaNova: Reaching End Of RECOVER And ANTHEM LivaNova names Vladimir Makatsaria as CEO LivaNova to wind down Advanced Circulatory Support business unit Seeking Alpha’s Quant Rating on LivaNova PLC His...

Vimeo Inc. (VMEO) is expected to report $-0.01 for Q4 2023 Heineken N.V ADR (HEINY) is expected to report for Q4 2023 American States Water Company (AWR) is expected to report $0.53 for Q4 2023 NextPlay Technologies Inc. (NXTP) is expected to report for Q3 2024 Inseego Corp. (INSG...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter and full year ended December 31, 2023 and issued guidance for 2024. Financial Summary and Highlights 1 Fourth-quarter revenue of $310.1 million increased 12.8 per...

2024-02-05 08:38:17 ET More on LivaNova PLC LivaNova: Reaching End Of RECOVER And ANTHEM LivaNova to wind down Advanced Circulatory Support business unit LivaNova reports cybersecurity incident, says IT systems disrupted Seeking Alpha’s Quant Rating on...

William Kozy will remain Board Chair LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its Board of Directors named Vladimir A. Makatsaria as the Company’s Chief Executive Officer (CEO) and a member of the Board of Directors, effective Marc...

2024-01-09 16:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...